-->

Member Access

Registration is free

Bookshelf

Kinase Drug Discovery (Rsc Drug Discovery)

by Richard A. Ward, Frederick Goldberg, David P. Rotella and David E. Thurston

KinaseInhBoook


Available in Dec 2011.

Visit our bookshelf for more books on Kinases and Kinase Inhibitors or pre-order this book today




B&W Powered

KKB Hot Article: Discovery of pyrimidine benzimidazoles as Src-family selective Lck inhibitors. Part II. PDF Print E-mail
Written by KKB   
Tuesday, 20 April 2010 19:33
Citation: Discovery of pyrimidine benzimidazoles as Src-family selective Lck inhibitors. Part II.
Authors: A series of 4-amino-6-benzimidazole-pyrimidines was designed to target lymphocyte-specific tyrosine kinase (Lck), a member of the Src-family kinases (SFKs). These type II inhibitors were optimized using a cellular Lck-dependent proliferation assay and are capable of inhibiting Lck at single-digit nanomolar concentrations. This scaffold is likely to serve a valuable template for developing potent inhibitors of a number of SFKs
PubMed PMID: 19854052
Abstract: A series of 4-amino-6-benzimidazole-pyrimidines was designed to target lymphocyte-specific tyrosine kinase (Lck), a member of the Src-family kinases (SFKs). These type II inhibitors were optimized using a cellular Lck-dependent proliferation assay and are capable of inhibiting Lck at single-digit nanomolar concentrations. This scaffold is likely to serve a valuable template for developing potent inhibitors of a number of SFKs
Targets: HCK, INSR, KDR, LCK, LYN, SRC
Number of SAR data points: 363
Number of Targets: 6
Last Updated on Saturday, 20 August 2011 00:07
 
Copyright © 2012 Kinase Data Portal. All Rights Reserved.
 

KinaseData Forum Latest Posts

No posts to display.

Featured Links:
Apple


B&W Powered

Fight Against Cancer